Thus, our findings evidence that the inhibition of a NOR-1-target gene prevented AAA development, emphasizing the role of both NOR-1 in VSMC and the TH biosynthetic route in the pathophysiology of this disease. The gene discussed is NR4A3; the disease is triple-A syndrome.